BlackRock Investment Management’s Collegium Pharmaceutical COLL Stock Holding History

BlackRock Investment Management’s Portfolio COLL Stock Details COLL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$913K	Buy	58,611 +7,140	+14%	+$119K	﹤0.01%	2746
2016 Q3	$991K	Sell	51,471 -75	-0.1%	-$891	﹤0.01%	2672
2016 Q2	$611K	Buy	51,546 +25,388	+97%	+$419K	﹤0.01%	2946
2016 Q1	$475K	Buy	26,158 +1,660	+7%	+$30.2K	﹤0.01%	2921
2015 Q4	$674K	Sell	24,498 -587	-2%	-$12.4K	﹤0.01%	2857
2015 Q3	$555K	Sell	25,085 -394	-2%	-$7.12K	﹤0.01%	2988
2015 Q2	$455K	Buy	+25,479	New	+$441K	﹤0.01%	3150

Other funds holding COLL

SAM

Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

TGHSA

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

CCM

Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return

BlackRock Investment Management's COLL Position: Q4 2016 in Review

BlackRock Investment Management increased its Collegium Pharmaceutical (COLL) stake by 14% in Q4 2016, buying an estimated $119K and bringing the position to 58,611 shares worth $913K. The position accounts for ﹤0.01% of the portfolio, ranked #2746.

BlackRock Investment Management first reported a position in COLL in Q2 2015 and has held it in 7 quarters since. The position peaked at $991K in Q3 2016. 88 funds tracked by Wall St. Rank hold COLL as of Q4 2016.

BlackRock Investment Management held 58,611 shares of Collegium Pharmaceutical worth $913K as of Q4 2016.
BlackRock Investment Management bought 7,140 Collegium Pharmaceutical shares in Q4 2016, an estimated $119K.
Collegium Pharmaceutical made up ﹤0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #2746 holding.
BlackRock Investment Management first reported a position in Collegium Pharmaceutical in Q2 2015 and has held it in 7 quarters since.
BlackRock Investment Management's Collegium Pharmaceutical position peaked at $991K in Q3 2016.
88 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.